CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Clinical Researchs Most Recent Developments

Clinical Researchs Most Recent...

Aceragen Receives Grant from Cystic Fibrosis Foundation to Advance Novel Therapy

Aceragen Receives Grant from Cystic...

Giuliano to Lead Finance-Related Leadership Functions as New CFO at Aeterna

Giuliano to Lead Finance-Related...

Top Ways Netsuite Transforms Life Science Industry for Good

Top Ways Netsuite Transforms Life...

Rain Therapeutics and Roche to Jointly Conduct Immunotherapy Trial Solid Tumor Treatment

Rain Therapeutics and Roche to...

China biopharma sector focuses on innovation.

China biopharma sector focuses on...

4 Common Challenges in Clinical Trials - How Are You Addressing Them?

4 Common Challenges in Clinical...

What are the Key Pain Points in Managing Clinical Trials?

What are the Key Pain Points in...

Clinical Researchs Most Recent Developments

Clinical Researchs Most Recent...

Aceragen Receives Grant from Cystic Fibrosis Foundation to Advance Novel Therapy

Aceragen Receives Grant from Cystic...

Giuliano to Lead Finance-Related Leadership Functions as New CFO at Aeterna

Giuliano to Lead Finance-Related...

Top Ways Netsuite Transforms Life Science Industry for Good

Top Ways Netsuite Transforms Life...

Rain Therapeutics and Roche to Jointly Conduct Immunotherapy Trial Solid Tumor Treatment

Rain Therapeutics and Roche to...

China biopharma sector focuses on innovation.

China biopharma sector focuses on...

4 Common Challenges in Clinical Trials - How Are You Addressing Them?

4 Common Challenges in Clinical...

What are the Key Pain Points in Managing Clinical Trials?

What are the Key Pain Points in...

Adherehealth and Levrx Technology Establish a Strategic Partnership to Improve Medication Optimization

Life Sciences Review | Tuesday, February 01, 2022
Tweet

Levrx is a forward-thinking software company transforming the healthcare experience one prescription at a time. Levrx connects providers, patients, pharmacies, and payers on a single platform to make prescribing easier and more affordable.


Fremont, CA: AdhereHealth, a healthcare technology company that drives prescription efficiencies and maximizes savings, formed a new integration partnership with Levrx Technology Inc today. This digital health technology company drives prescription efficiencies and maximizes savings. By integrating Levrx's plan-specific and real-time prescription insights into the Adhere Platform's Medication Optimization solution, their combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions.


The rising cost of pharmacy is one of the most significant challenges in American healthcare. According to the Centers for Medicare and Medicaid Services (CMS), prescription spending for private insurance and state-run programs was $348.4 billion in 2020, according to the Centers for Medicare and Medicaid Services (CMS), and is expected to reach $560.3 billion by 2028. As total costs continue to rise, member cost-sharing increases, as does concern medication non-adherence. According to statistics, at least 12.8 million adults delayed or did not obtain prescription drugs in 2018-19 due to cost.


"When prescriptions exceed $125, more than half of them are abandoned at the pharmacy," said Jason Z. Rose, CEO of AdhereHealth. "Our Medication Optimization solution now includes formulary cost savings analytics and technologies, 


which address lower-cost medication options for the patient, health plan, and employer, thanks to our collaboration with Levrx. These insights can be used by care teams to improve medication adherence and deliver immediate and long-term cost savings."


The Medication Optimization solution, anchored within the Adhere PlatformTM, generates insights based on medical claims, pharmacy claims, and direct patient and provider engagement to identify patients at high risk of non-adherence automatically. To prioritize high-risk patients and guide personalized outreach, the system generates targeted analytics that is updated daily and integrated into various clinical workflows. Predictive analytics insights provide actionable insights to care teams as they engage high-risk patients to close critical medication optimization gaps.


AdhereHealth can now increase its impact by incorporating prescription formulary opportunity analytics into its data-driven medication optimization workflow, thanks to the addition of Levrx capabilities. The Adhere Platform uses these analytics to notify clinicians when lower-cost alternatives are available. As a result, the provider is given the authority to proactively coordinate with the patient and the provider to prescribe the appropriate medication, reduce non-adherence, and improve health outcomes. The Adhere Platform's analytics, on the other hand, is integrated into Levrx Practice AppTM technology workflows for providers.


Weekly Brief

loading
Top 10 Clinical Trial Services Companies - 2022
Top 10 Emerging Clinical Trial Management Companies - 2022
Top 10 Clinical Trial Management System Companies - 2022
Top 10 Clinical Trial Services Companies - 2022
Top 10 Emerging Clinical Trial Management Companies - 2022
Top 10 Clinical Trial Management System Companies - 2022
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing
Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/adherehealth-and-levrx-technology-establish-a-strategic-partnership-to-improve-medication-optimization-nwid-706.html